Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Atherosclerosis|February 1, 1986
Pharmacological profile of tazasubrate, a new cholesterol-lowering agentE Schulze, J Obermaier, C A Seyfried, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 26, 2008
Delivery of nanoparticles to the brain detected by fluorescence microscopyIsolde Reimold, Diana Domke, Joe Bender, et al.
Journal of Neural Transmission|January 1, 1987
The characterization of the dopaminergic profile of EMD 23,448, and indolyl-3-butylamine: selective actions on presynaptic and supersensitive postsynaptic DA receptor populationsM Goldstein, K Fuxe, E Meller, et al.
Neurochemistry International|May 27, 2010
Prodynorphin processing by rat CNS fractions and purified enzymes: Formation of Dynorphin A 1-8 by sulfhydryl-activated carboxypeptidase and peptidyl dipeptidaseN Marks, M J Berg, M Benuck, et al.
Journal of Medicinal Chemistry|October 30, 1992
Synthesis and dopaminergic activity of some 3-(1,2,3,6-tetrahydro-1-pyridylalkyl)indoles. A novel conformational model to explain structure-activity relationshipsH Böttcher, G Barnickel, H H Hausberg, et al.
Journal of Medicinal Chemistry|September 3, 2004
Indolebutylamines as selective 5-HT(1A) agonistsTimo Heinrich, Henning Böttcher, Gerd D Bartoszyk, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
SAR of novel biarylmethylamine dopamine D4 receptor ligandsM Arlt, H Böttcher, A Riethmüller, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 10, 2004
Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profileG D Bartoszyk, C Van Amsterdam, H E Greiner, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 18, 1999
Effects of GR-89696 and the novel peripherally selective OP2 agonists, EMD-61569 and EMD-61747, against focal cerebral ischemia in the ratA Barber, H M Bender, R Gottschlich, et al.
Journal of Medicinal Chemistry|March 29, 2000
5-HT reuptake inhibitors with 5-HT(1B/1D) antagonistic activity: a new approach toward efficient antidepressantsL Matzen, C van Amsterdam, W Rautenberg, et al.
Pageof 4